Boston Scientific Corp (NYSE:BSX)
| 54.93 Delayed Data As of Dec 08 |  -0.10 / -0.18%Today’s Change | 44.35 Today|||52-Week Range 56.22 | +18.72% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 2.4B | 2.6B | 2.5B | 2.6B | |
| Cost of Goods Sold | 586.0M | 640.0M | 670.0M | 701.0M | ||
| Depreciation And Amortization | 222.0M | 245.0M | 229.0M | 234.0M | ||
| Operating Expenses | Gross Income | 1.6B | 1.7B | 1.6B | 1.7B | |
| General Expenses | 1.2B | 1.2B | 1.1B | 1.2B | ||
| Other Operating Expenses | 17.0M | 18.0M | 16.0M | 17.0M | ||
| Research And Development | 289.0M | 288.0M | 280.0M | 280.0M | ||
| Total Operating Expenses | 2.0B | 2.1B | 2.1B | 2.2B | ||
| Non-Operating Expenses | Operating Income | 411.0M | 424.0M | 429.0M | 431.0M | |
| Extraordinary Credit | 29.0M | 26.0M | 176.0M | -- | ||
| Extraordinary Charge | -33.0M | -122.0M | -78.0M | -215.0M | ||
| Interest Expense On Debt | 68.0M | 74.0M | 114.0M | 98.0M | ||
| Other Expenses | 118.0M | 41.0M | 37.0M | 13.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 456.0M | 296.0M | 457.0M | 145.0M | |
| Income Taxes | -24.0M | -90.0M | -33.0M | -9.0M | ||
| Net Income | 432.0M | 386.0M | 424.0M | 154.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.4B | 1.4B | 1.4B | 1.4B | |
| Shares To Calculate EPS Diluted | 1.4B | 1.4B | 1.4B | 1.4B | ||
| Earnings Per Share | EPS | $0.31 | $0.27 | $0.30 | $0.11 | |
| EPS Diluted | $0.31 | $0.27 | $0.30 | $0.11 | ||
